Pharmacovigilance of over-the-counter products based in community pharmacy: A feasible option?

Citation
Hk. Sinclair et al., Pharmacovigilance of over-the-counter products based in community pharmacy: A feasible option?, PHARMA D S, 8(7), 1999, pp. 479-491
Citations number
25
Categorie Soggetti
Pharmacology
Journal title
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
ISSN journal
10538569 → ACNP
Volume
8
Issue
7
Year of publication
1999
Pages
479 - 491
Database
ISI
SICI code
1053-8569(199912)8:7<479:POOPBI>2.0.ZU;2-Y
Abstract
Purpose: With the increasing range of potent medicines available for sale ' over-the-counter' (OTC) in community pharmacies, this feasibility study set out to develop and validate a method for the pharmacovigilance of OTC medi cine, using ibuprofen as a model. Method: A trained network of community pharmacies (n = 61) in Grampian, Sco tland, tested different methods for recruiting people buying ibuprofen for their own use (pilot 1) and then used the 'best' method to test two methods of follow-up (pilot 2). Results: Recruitment rates - method 1 (pharmacy staff inserted the patient information sheet and recruitment questionnaire in the shop bag of eligible subjects): 18% (41/227) of questionnaires issued; method 2 (staff explaine d the study and asked eligible subjects to complete the questionnaire outwi th the pharmacy): 31% (61/194); method 3 (staff explained the study and ask ed eligible subjects to complete the questionnaire in the pharmacy): 52% (1 00/192). A further 200 subjects were recruited in pilot 2. The majority of recruits (n = 402) were female (75%), mean ape 43 years (range 18-84 years) , 73% drank alcohol, 72% were non-smokers, and 56% were in the two most aff luent socio-economic categories. There was a strong association between the drug dose data collected prospectively and that collected retrospectively. The average response to postal follow-up was 80% (315/392) at 1 week and 7 9% (308/390) at 2 months. Conclusion: The study has confirmed the support of pharmacy personnel in un dertaking research and indicated the feasibility of a major pharmacovigilan ce project of OTC medicines. Copyright (C) 1999 John Wiley & Sons, Ltd.